Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Beam

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.

Biotech stocks put up a split showing at JPM, where names like BridgeBio, ARS and Harmony stood out with strong preliminary reports.

Investors Business Daily

1 'Strong Buy' Penny Stock With 259% Upside Potential

BEEM stock has underperformed in 2024. Should you bet on a comeback year in 2025?

Barchart

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains

Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Index Futures Gain With U.S. Presidential Election in Focus, Economic Data and Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are up +0.21%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.27% this morning as investors braced for the closely contested U.S. presidential election, while also awaiting a new round of economic data and corporate earnings reports.

Barchart

Social workers in England begin using AI system to assist their work

Magic Notes tool records and analyses face-to-face meetings and suggests follow-up actions

The Guardian - UK

E-scoot boot: A purple patch of mobility vanishes from Canberra streets

Beam e-scooters sent packing after government ban.

The Canberra Times

Beam to face big fines if its scooters don't get removed in time

Beam trying to refund customers who have subscriptions.

The Canberra Times

Read news from The Economist, FT, and more,
with one subscription

Get your scooters out of town: ACT govt kicks out Beam

Beam had 250 secret scooters on the streets of Canberra.

The Canberra Times

Brisbane e-scooter operator Beam loses licence over alleged breach of daily cap

City council alleges cap on scooter numbers ‘systematically exceeded’ by 500 a day but company ‘disagrees’ with claims, saying it is ‘reviewing options’

The Guardian - AU

Auckland 'deactivates' Beam e-scooters as ACT considers action

Will the ACT follow Auckland and axe Beam e-scooters from the streets?

The Canberra Times

Verbal street war over Canberra e-scooters

Neuron accuses Beam of 'reprehensible' conduct.

The Canberra Times

ACT govt investigating 'unethical' conduct by e-scooter operator Beam

Beam apologises for breaching vehicle caps, denies it was intentional.

The Canberra Times

Unusual Options Point to Something Cooking for Beam Global (BEEM)

With renewed interest in the electric vehicle space, BEEM stock could potentially continue its remarkable rally due to the underlying charging infrastructure business.

Barchart

‘A death sentence for music’: the battle for America’s last Live Nation-free city

Portland has no Live Nation concert arena, and fans and artists love its fiercely independent music scene. But with a new venue looming, will all that change?

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

Creative Bloq

"If design work doesn’t provoke a response, then it’s in danger of being wallpaper": a day in the life of David Palmer

LOVE's founder and ECD talks provocation, grief and reimagining Jim Beam's 400-acre distillery.

Newcastle Herald

Purple e-bikes and scooters come to a grinding halt in Lake Macquarie

Beam Mobility has announced it will cease operations this week.

MusicRadar

Seeing is believing with BEAM, Lunacy’s striking new granular and convolution processor that keeps you in your creative flow

Fashion Times

Hit Reset On Your Spring Beauty Routine

The arrival of a new season means it's time to refresh and reset your beauty routine. Here's a guide on how to elevate your skincare game for spring.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Beam Rockets 26%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug

Beam stock launched a year-high Tuesday as enthusiasm grows for its next-generation form of gene editing, a rival to CRISPR.

Investors Business Daily

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

Biotech stocks are heating up as multibillion-dollar deals pile up and new modalities like CRISPR gene-editing hit prime time.

The Canberra Times

Drunk rider detection tests set to stamp out 'anti-social' e-scooter riders

The technology will be installed in time for Summernats.

The Guardian - US

I’m afraid of heights. Could I re-create the famous New York skyscraper beam photo?

A new attraction at the Rockefeller Center allows visitors to stage Lunch atop a Skyscraper, at a less scary 12ft off the ground

Investors Business Daily

Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners

Cathie Wood's flagship Ark Innovation ETF ARKK just had its best week ever thanks to Roku, DraftKings, Palantir and other huge winners on big news.

Investors Business Daily

Verve Stock Soars On $250 Million Eli Lilly Deal

Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.

Barchart

3 EV Stocks Under $10 Analysts Expect To Triple

Analysts expect these three EV stocks to charge ahead, with significant upside potential projected from current price levels.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.